02.07.2019

The independent credit rating agency «Credit-Rating» confirmed the long-term credit rating of Borshchahivskiy CPP as uaAA+. The outlook for the rating is stable, indicating that there are currently no prerequisites for changing the rating over the year.

A uaAA rating is characterized by very high creditworthiness of the enterprise compared to other Ukrainian borrowers or debtors. The «+» sign means an intermediate rating category relative to the main categories.

To update the credit rating, BCPP provided financial statements for the 2nd half of the year and 2018 as a whole, as well as internal information during the rating process.

In particular, the increase in the rating is facilitated by significant investments in the development of the plant, information openness and transparency of the enterprise. Also, the positive impact on the rating has a profitable operating activity and a significant experience of the work of the governing body of the BCPP.

«The confirmation of the credit rating testifies to the efficiency and effectiveness of the company's approach to its development. In particular, a high rating helps patients and partners identify the most stable representative of the pharmaceutical market, – Yuliia Zdarevska, CEO of BCPP. – Speaking about the activities of BCPP in 2018 – despite the difficult economic situation in the country, we invested almost 162 million USD in improving the company, and by the end of 2019 we plan to invest over 63 million USD for the development and reconstruction of production».